ウムブラリシブ 化学特性,用途語,生産方法
効能
抗悪性腫瘍薬
説明
Umbralisib (TGR-1202) tosylate is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50
of 22.2 nM and 6.0 μM, respectively. Umbralisib tosylate exhibits
unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T
cells. Umbralisib tosylate can be used for haematological malignancies
reseach.
使用
RP 5264 is a novel PI3K inhibitor that enhances Brentuximab Vedotin-induced lymphoma cell death.
brand name
Ukonig
ウムブラリシブ 上流と下流の製品情報
原材料
準備製品